November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting...read more
IO Biotech, a Phase 3-ready biotech developing immunotherapies for melanoma and other cancers, raised $100 million by offering 7.2 million shares at $14, the low end of the range of $14 to $17. The company offered 0.7 million more shares than anticipated. IO...read more
IO Biotech, a Phase 3-ready biotech developing immunotherapies for melanoma and other cancers, announced terms for its IPO on Monday. The Copenhagen, Denmark-based company plans to raise $101 million by offering 6.5 million shares at a price range of $14 to $17...read more
Updated Monday, 11/1. The IPO market has seen double digit offerings for the past two weeks, and is scheduled to continue its streak, with 13 IPOs expected to raise $2.7 billion. Drug discovery company Evotec (EVO) plans to raise...read more
US IPO Weekly Recap: Allbirds spreads its wings and soars 93% in a 12 IPO week
November kicked off with a 12 IPO week and shoe brand Allbirds (BIRD) was at the front of the flock, posting a first-day pop of 93%. 23 SPACs also went public. New issuers continued to join the pipeline, with five IPOs and 13 SPACs submitting...read more
Immuno-oncology biotech IO Biotech prices IPO at $14 low end
IO Biotech, a Phase 3-ready biotech developing immunotherapies for melanoma and other cancers, raised $100 million by offering 7.2 million shares at $14, the low end of the range of $14 to $17. The company offered 0.7 million more shares than anticipated. IO...read more
Immuno-oncology biotech IO Biotech sets terms for $101 million US IPO
IO Biotech, a Phase 3-ready biotech developing immunotherapies for melanoma and other cancers, announced terms for its IPO on Monday. The Copenhagen, Denmark-based company plans to raise $101 million by offering 6.5 million shares at a price range of $14 to $17...read more
US IPO Week Ahead: Steady IPO deal flow set to continue with 13 IPOs slated for next week
Updated Monday, 11/1. The IPO market has seen double digit offerings for the past two weeks, and is scheduled to continue its streak, with 13 IPOs expected to raise $2.7 billion. Drug discovery company Evotec (EVO) plans to raise...read more